Becton Dickinson & Company
Becton Dickinson & Company is a global medical technology company specializing in the manufacturing of medical devices, diagnostic products, and reagents.
Price history of Becton Dickinson & Company
Price history of Becton Dickinson & Company
Performance & Momentum
Becton Dickinson valued up amid positive outlook
Becton Dickinson & Company (NYSE: BDX) is drawing analyst attention with a valuation considered up to 40% undervalued based on intrinsic valuation methods. RBC Capital recently raised its price target to $210 while maintaining a 'Sector Perform' rating, highlighting the company's sustainable growth. Additionally, insiders have increased their stakes, signaling strong internal confidence. These factors combined may support the stock in the medium term on the NYSE.
Strategic Analysis
Becton Dickinson & Company • 2026
Becton Dickinson & Company occupies an essential global supplier position in medical devices, diagnostics, and reagents, with a diversified portfolio at the heart of healthcare delivery. Its business model is built on recurring usage, a strong hospital footprint, and high barriers to entry tied to regulation, industrial quality, and long-term relationships with healthcare institutions.
- Exposure to structural, non-discretionary healthcare needs, supporting relatively resilient demand
- Diversified portfolio across devices, diagnostics, and consumables, reducing dependence on a single product line
- International positioning with an established presence among hospitals and laboratories, which supports recurring business
- Growth is often steadier than spectacular, limiting the potential for a rapid rerating
- Potential sensitivity to margin pressure in medical devices and to capital spending cycles at healthcare institutions
Momentum appears moderately positive, with a recent rebound that contrasts with a weaker trajectory over intermediate and longer periods. The stock seems to be in a cautious recovery phase rather than in a clearly sustained uptrend, making it a quality defensive name to watch rather than a strong acceleration story.
Similar stocks to Becton Dickinson & Company
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases